SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 307.42 |
Enterprise Value ($M) | 437.31 |
Book Value ($M) | -71.48 |
Book Value / Share | -5.99 |
Price / Book | -4.30 |
NCAV ($M) | -89.82 |
NCAV / Share | -7.53 |
Price / NCAV | -3.42 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.87 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.04 |
Current Ratio | 2.04 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 28.72 |
Assets | 47.06 |
Liabilities | 118.53 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | -6.65 |
Operating Income | -48.26 |
Net Income | -53.74 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.68 |
Cash from Investing | -0.01 |
Cash from Financing | 0.41 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Acorn Bioventures, L.p. | 6.70 | ||
13D | Atlas Venture Fund X, L.P. | 7.20 | ||
13G | Carlyle Group Inc. | 9.20 | ||
13D | Orbimed Advisors Llc | 18.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,584 | 13,508 | 11.73 | |
7,327 | 12,169 | 60.21 | |
2,288 | 3,409 | 67.12 | |
1,714 | 2,999 | 57.15 | |
(click for more detail) |
Similar Companies | |
---|---|
PROC – Procaps Group S.A. | PTGX – Protagonist Therapeutics, Inc. |
PWUP – PowerUp Acquisition Corp. | RANI – Rani Therapeutics Holdings, Inc. |
RAPT – RAPT Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io